Optimal Follow-Up Duration for Assessment of Birth Defects After In Vitro Fertilization–Embryo Transfer: A Multicenter 5-Year Cohort Study in China

• Published in: Frontiers in endocrinology (Lausanne) 2022-03, Vol.13, p.817397-817397, Article 817397
• Main Authors: Liu, Chun-Lin, Li, Ping, Cai, Gui-Feng, Morse, Abraham, Liu, Jun, Chen, Zhi-Heng, Zhang, Xiu, Sun, Ling
• Format: Article
• Language: English
• Subjects: birth defects; Child; Child, Preschool; Cohort Studies; cohort study; Embryo Transfer; Endocrinology; Female; Fertilization in Vitro - adverse effects; follow-up duration; Follow-Up Studies; Humans; in vitro fertilization (IVF); Infant; loss to follow-up (LTFU); Pregnancy; Reproductive Techniques, Assisted
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2022.817397

To investigate the impact of a 5-year follow-up on the incidence of identified birth defects in children conceived using assisted reproductive technologies (ART). A 5-year cohort study was performed in three ART centers from January 2013 to October 2018. 1,543 women with 1,985 infants who delivered successfully or underwent termination of pregnancy due to malformations were recruited in this study. Follow-up was conducted by phone interview, 7 days, 1 year, 3 years, and 5 years after birth. Collected data included whether one or more birth defects were diagnosed, the category of birth defects, and when the malformation was diagnosed. Cumulative incidence of birth defects and the loss to follow-up rate of each follow-up was compared. According to the diagnostic criterion of birth defects, 111 cases of one or more birth defects were recorded, with a total of 117 birth defects after the 5-year follow-up. 0.2% (4/1,985) of birth defects were diagnosed before delivery; 2.7% (54/1,985) at 7 days; 5.0% (100/1,985) after 1 year; 5.5% (109/1,985) after 3 years; and 5.6% (111/1,985) after 5 years. 3.4% (4/117) of defects were diagnosed prenatally, 45.3% (53/117) of defects diagnosed within the first 7 days after delivery, 40.2% (47/117) diagnosed during 7 days to 1 year, and 9.4% (11/117) of defects diagnosed in 1-3 years after birth. The remaining 1.7% (2/117) of defects were diagnosed between the ages of 3 and 5 years. Among the 1,543 patients, 99.9% patients (1,542/1,543) responded to the telephone interview at 7 days after delivery; the response rate was 89.0% (1,373/1,543) at 1 year, 81% (1,250/1,543) at 3 years, and 64.5% (995/1,543) after 5 years. We suggest that in ART, 1-year follow-up should be the minimum requirement and 3-year follow up the optimal length of follow-up that balances resource requirements with ascertainment completeness.